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Summary
Mitochondrial dysfunction plays a primary role in the pathogenesis of Parkinson’s disease (PD), particularly in autosomal recessive
forms of the disease caused by mutations encoding PINK1. Although mitochondrial pathology can be demonstrated in many cell types, it
is neurons that bear the brunt of cell death in PD. We studied the mitochondrial physiology of neurons and muscle cells with loss of
function of the nuclear encoded mitochondrial protein PINK1. PINK1 is widely expressed in many types of tissues, but deficiency
selectively induces death in neurons. We report here that the same genetic defect results in opposing phenotypes in different cell types,
depending on the metabolic properties of the cell. Thus, PINK1-deficient myocytes exhibit high basal mitochondrial membrane potential
(Dym), whereas PINK1-deficient neurons have been shown to exhibit a low Dym. PINK1 deficiency induces impaired respiration in
both cell types, with a concomitant increase in glycolytic activity. We demonstrate that the high glycolytic capacity in myocytes
compared with neurons enables them to produce more ATP and, therefore, compensates for the metabolic defects induced by PINK1
deficiency. Furthermore, the high Dym generated in PINK1 knockout (KO) muscle mitochondria enables them to buffer cytosolic Ca2+
fluxes, rendering them resistant to Ca2+ stress effectively. Conversely, PINK1 KO neurons were previously shown to develop
mitochondrial Ca2+ overload and Ca2+-induced mitochondrial depolarisation. Prevention of Ca2+ dysregulation in myocytes might
therefore account for the sparing of these cells in PD.
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Introduction
Parkinson’s disease (PD) is one of the most common
neurodegenerative diseases and is characterised pathologically
by loss of dopaminergic neurons in the substantia nigra and
the formation of Lewy bodies. Mitochondrial dysfunction is
associated with a range of neurodegenerative diseases, and in
particular PD (Bueler, 2009). The identification of mutations in
genes that cause familial recessive PD (such as DJ-1, PINK1 and
parkin) has improved our understanding of the mitochondrial
pathophysiology that might occur in both mendelian and sporadic
forms of the disease.
One of the major conundrums of mendelian PD remains that the
genetic defect is found in all cell types, and the affected proteins
are often expressed in all tissues, but it is neurons that are uniquely
susceptible to cell death in the human disease. Similarly, in
sporadic PD, mitochondrial dysfunction is strongly implicated in
the pathogenesis, and mitochondrial abnormalities have been
demonstrated in cells other than neurons – for example, reduced
complex 1 activity in muscle cells and platelets of patients with
PD. However, tissue types that are heavily reliant on mitochondrial
function, such as muscle, are typically spared in neurodegenerative
disease, but are frequently affected in primary mitochondrial
disease, where myopathy is common. In order to investigate the
selective vulnerability of neurons compared with myocytes, we
used a mendelian PD model, in which mutations in the PINK1
gene result in loss of function of a nuclear-encoded mitochondrial
protein. We compared the effects of PINK1 deficiency on cell
metabolism and mitochondrial function in two different types of
primary PINK1 knockout (KO) mouse cells: neurons and skeletal
myocytes.
Mutations in the PINK1 gene have been shown to cause
autosomal recessive PD (Valente et al., 2004). PINK1 is a putative
serine/threonine-protein kinase, homologous to the kinases of the
Ca2+/calmodulin family. The PINK1 protein is predicted to contain
a mitochondrial targeting motif and has been shown to be localised
to mitochondria (Gandhi et al., 2006; Muqit et al., 2006), although
a cytosolic pool of PINK1 has also been described (Beilina et al.,
2005; Haque et al., 2008; Lin and Kang, 2008; Weihofen et al.,
2008). PINK1 is cleaved by the mitochondrial protease PARL, and
this cleavage is important for the function of both PINK1 and
mitochondria (Deas et al., 2011; Jin et al., 2010). There are many
putative roles for PINK1 in mitochondrial function. A number
of studies have demonstrated that PINK1 deficiency results in
decreased Dym, and increased reactive oxygen production and
mitochondrial Ca2+ mishandling in mammalian cells (Exner et al.,
2007; Piccoli et al., 2008; Wood-Kaczmar et al., 2008; Gegg et al.,
2009; Yuan et al., 2010; Gandhi et al., 2009). It has also been
suggested that PINK1 affects mitochondrial function by regulating
mitochondrial fission and fusion in both mammalian cells and
Drosophila (Deng et al., 2008; Poole et al., 2008; Yang et al.,
2008; Dagda et al., 2009; Lutz et al., 2009; Cui et al., 2010; Kamp
et al., 2010). More recently, several studies have demonstrated that
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PINK1 can play an important role in recruiting parkin to damaged
mitochondria, thus regulating the degradation of mitochondria
through autophagy (Geisler et al., 2010; Kawajiri et al., 2010;
Narendra et al., 2010; Vives-Bauza et al., 2010; Ziviani et al.,
2010).
In this study, we demonstrate that loss of PINK1 function
increased basal Dym in skeletal myocytes, as opposed to
previously reported decreased basal Dym in neurons. We show
that this opposite response in Dym is due to the difference in ATP
metabolism between neurons and myoctyes. Furthermore, the
difference in basal Dym results in differential effects on
mitochondrial Ca2+ buffering capacity and on cell survival.
Thus, the differential ability of the metabolic environment of
muscle cells and neurons to compensate for PINK1 deficiency
results in a different phenotype and different susceptibility to cell
death in these cell types.
Results
Mitochondrial membrane potential is increased in PINK1
KO myocytes and decreased in PINK1 KO neurons and
fibroblasts
PINK1 KO skeletal myocytes exhibited a significant increase in
basal Dym by 98.7±40.5% compared with that of wild-type
(WT) myocytes (Fig. 1A). By contrast, the basal Dym is reduced
in primary PINK1 KO midbrain neurons – tetramethyl rhodamine
methyl ester (TMRM) fluorescence for PINK1 KO neurons is
63.7±4.2% of WT neurons (Fig. 1A). Similarly in fibroblasts,
TMRM fluorescence was reduced for PINK1 KO fibroblasts to
63.4±7.3% compared with that in WT. These data indicate that
PINK1 deficiency is associated with the alteration of the basal
Dym, but the direction of this effect varies in different cell types.
To further understand the effects of PINK1 KO on the
mechanism of maintenance of the Dym, we assessed the
response of Dym to a range of mitochondrial inhibitors in
primary neuronal and myocyte cultures.
Oxidative respiration is impaired in PINK1 KO myocytes
Application of the F1Fo-ATPase inhibitor oligomycin (2 mg/ml)
caused marked mitochondrial depolarization in PINK1 KO
myocytes (Dym dropped by 57.9±5.0%, Fig. 1B), indicating that
the Dym in PINK1 KO myocytes must be partially maintained by
the hydrolysis of ATP by the F1Fo-ATPase, rather than solely by
respiration. By contrast, application of oligomycin in WT
myocytes did not alter the Dym, indicating that the Dym is
usually maintained by respiration. We then exposed cells to
respiratory chain substrates. Interestingly, even in conditions of
high basal Dym in PINK1 KO myocytes, application of 5 mM
pyruvate or 5 mM methyl succinate induced a further increase in
Dym (Fig. 1C) and prevented the oligomycin-induced
depolarisation described above. Therefore, the provision of
pyruvate switched the mechanism of maintenance of Dym to be
dependent on the respiratory chain rather than on the hydrolysis of
ATP. These results demonstrate that PINK1 KO myocytes, as well
as PINK1 KO neurons (Gandhi et al., 2009) maintain their Dym
using the same mechanism of hydrolyisis of ATP when there is an
insufficient substrate supply to the respiratory chain.
ATP levels are highest in muscles and lowest in midbrain
We investigated whether the difference in basal Dym between
myocytes and neurons might be attributable to a difference in ATP
supply. We therefore measured the ATP concentration in midbrain
and skeletal muscle tissues from PINK1 KO mice and WT
littermates. As expected, the ATP concentration in skeletal muscle
samples was substantially higher than in midbrain samples of
the same mouse – WT midbrain: 41.8±11.4 nmoles/mg protein,
WT muscle: 465.5±132.0 nmoles/mg protein, KO midbrain:
44.0±9.7 nmoles/mg protein, KO muscle: 835.5±216.2 nmoles/mg
protein. The sample size was n53 animal for each genotype
(Fig. 2A).
PINK1 KO myocytes exhibit a higher ratio of
glycolysis:oxidative phosphorylation than PINK1 KO
neurons
To investigate the major source of ATP production – that is,
oxidative phosphorylation or glycolysis we assessed the
Fig. 1. Dym in PINK1 KO skeletal myocytes, fibroblasts and neurons.
(A) Dym was measured using TMRM in primary neuronal cultures and
skeletal muscle and fibroblast cultures. Dym was reduced in PINK1 KO
neurons and fibroblasts, but increased in PINK1 KO myocytes compared with
the WT. A summary of mean values normalised to WT (±s.e.m.) is shown:
myocytes, 198.7±40.5%; neurons, 63.7±4.2%; fibroblasts, 63.4±7.3%,
*P,0.05. (B) Representative traces showing dynamic response of Dym in
response to oligomycin, rotenone and carbonyl cyanide-p-(trifluoromethoxy)
phenylhydrazone (FCCP). In WT myocytes, oligomycin did not affect Dym;
rotenone induced partial depolarization; FCCP induced complete
depolarization. In PINK1 KO myocytes, oligomycin induced mitochondrial
depolarization. (C) Application of 5 mM pyruvate or 5 mM methyl succinate
to PINK1 KO myocytes increased basal Dym and prevented
oligomycin-induced mitochondrial depolarization in PINK KO cells. Error
bars represent mean + s.e.m.
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expression of the b-subunit of the F1-ATPase (b-F1-ATPase) and
the glycolytic enzyme GAPDH (glycolytic glyceraldehyde-3-
phosphate dehydrogenase) in midbrain and skeletal muscle
from 9–11-month-old PINK1 KO mice and WT littermates
(Fig. 2B,C). The ratio between b-F1-ATPase and GAPDH
demonstrates the ratio between oxidative phosphorylation and
glycolysis and has been previously reported as a marker for
alteration in bioenergetics in tumours (Cuezva et al., 2002). In
WT and KO mice, the GAPDH:b-F1-ATPase ratio is 3.4±0.8 and
3.5±0.8 fold higher in the skeletal muscle compared with
midbrain (n56 animals for each genotype, Fig. 2C), confirming
the existence of higher levels of glycolysis in muscle compared
with midbrain. For each type of tissue, the GAPDH:b-F1-ATPase
ratio is similar between WT and KO mice.
PINK1 KO triggers an increase in glycolysis in both
myocytes and neurons
We assessed the metabolic rate of the cells by measuring the ATP
depletion rate, in the presence of inhibitors of glycolysis and/or
oxidative phosphorylation. The Mag-Fura-2 AM (hereafter
referred to as Mag-Fura) fluorescent probe was used as an
indicator of ATP consumption. The energy capacity of the cell
is defined as the time between application of inhibitors
of glycolysis and/or ATP-synthase (i.e. cessation of ATP
production) to the time of cell lysis (i.e. energetic collapse due
to total ATP depletion and inability to maintain Ca2+
homeostasis).
Inhibition of glycolysis by 1 mM iodoacetic acid (IAA),
resulted in a progressive increase in cellular Mg2+ ([Mg2+]c)
owing to ATP depletion, and eventually led to cell lysis
(Fig. 3A).
Inhibition of glycolysis in myocytes did not result in a significant
difference in the ATP depletion rate or the energy capacity of the
cell when comparing WT with PINK1 KO myocytes – the Mag-
Fura 340 nm and 380 nm emission ratio (hereafter referred to as
Mag-Fura 340:380 ratio) change per minute was measured as: WT
myocytes 0.0053±0.00039, KO myocytes 0.0057±0.00046
(Fig. 3B). In contrast to myocytes, the rate of ATP depletion was
substantially higher in PINK1 KO neurons – the Mag-Fura 340:380
ratio change per minute was: WT neurons 0.00060±0.00025, KO
neurons 0.0023±0.00007 (Fig. 3B). Furthermore, the time for the
cells to consume all their ATP (cell lysis time) was notably shorter
in the PINK1 KO neurons compared with the WT: WT neurons
98.67±5.52 minutes, KO neurons 69.27±2.25 minutes (Fig. 3B). It
is possible that the higher rate of ATP depletion and the reduced
energy capacity observed in PINK1 KO neurons are attributable to
the hydrolysis of ATP by F1Fo-ATPase in order to maintain the
Dym in neurons.
Next, we applied an inhibitor of oxidative phosphorylation,
oligomycin (2 mg/ml), and an inhibitor of the respiratory chain,
NaN3, and measured the ATP depletion rate and the energy
capacity of the cell once again. Inhibition of oxidative
phosphorylation in PINK1 KO neurons led to a substantial
decrease in the ATP depletion rate. The Mag-Fura 340:380 ratio
change per minute was: WT neurons 0.011±0.0025, KO neurons
0.0036±0.0002 (Fig. 3C). Furthermore, this was associated with
an increase in the time to cell lysis of the KO compared with
WT neurons: WT neurons 18.31±0.94 minutes, KO neurons
23.15±0.79 minutes (Fig. 3C). Similar effects were observed in
myocytes. Inhibition of oxidative phosphorylation led to a
decrease in the ATP depletion rate in PINK1 KO myocytes –
Mag-Fura 340:380 ratio change per minute: WT myocytes
0.0031±0.00016, KO myocytes 0.0024±0.00013 (Fig. 3C), and
an increase in cell lysis time compared with the WT: WT
myocytes 207.5±2.54 minutes, KO myocytes 246.9±7.28
(Fig. 3C).
Taken together, these data suggest two features: first, PINK1-
deficient cells have increased glycolysis to drive ATP production,
and thus, inhibition of glycolysis results in faster ATP depletion
and reduced energy capacity. Second, the major source of ATP
consumption in PINK1 KO cells is the hydrolysis of ATP by the
F1Fo-ATPase, and thus, inhibition of the ATPase results in a
slowing of the ATP depletion rate and an increase in the energy
capacity of the cell.
In order to estimate the overall ATP consumption in WT and
PINK1 KO myocytes and neurons, we applied both inhibitors
of glycolysis [iodoacetic acid (IAA), 20 mM] and F1Fo-ATP
synthase (oligomycin, 2 mg/ml). As shown in Fig. 3C, there is no
statistically significant difference between the rate of ATP
consumption and cell lysis time in response to both inhibitors
between PINK1 KO and WT myocytes. However, neurons with
Fig. 2. ATP concentration and glycolysis/oxidative phosphorylation
ratio. (A) The level of ATP is higher in both PINK1 KO and WT skeletal
muscle tissues compared with midbrain tissues from the same animal,
*P,0.05. (B) Representative western blot demonstrating the expression of
GAPDH and the b-F1-ATPase in midbrain and skeletal muscle tissues of
PINK1 KO and WT mice. (C) Densitometry analysis showing the ratio
between GAPDH and the b-ATPase. The ratio was higher in skeletal muscle
tissues compared with midbrain, and there was no substantial difference
between WT and KO tissues. KO midbrain, 1.0±0.1 fold of WT midbrain;
WT cortex, 3.4±0.8 fold of WT midbrain; KO cortex, 3.5±0.8 fold of WT
midbrain, n5six animals for each genotype, *P,0.05. Error bars represent
mean ± s.e.m.
Journal of Cell Science 124 (24)4196
Jo
u
rn
a
l
o
f
C
e
ll
S
ci
e
n
ce
PINK1 KO demonstrated a higher rate of ATP consumption,
suggesting a higher metabolic rate in PINK1 KO neurons
compared with WT neurons (WT neurons: 0.0023±0.00021,
KO neurons: 0.0029±0.00012, Fig. 3D).
Increased glycolysis induced by PINK1 KO can protect
cells against ischaemia
In order to assess whether the increased glycolysis in PINK1 KO
cells has an effect on cell survival, neurons and skeletal myocytes
were exposed to 50 minutes ischaemia followed by 30 minutes
reoxygenation (the time taken for the loading of the dyes). This
ischaemic injury results in significant levels of cell death in WT
neurons (40.3±3.0%, Fig. 4). Interestingly, the same ischaemic
injury in PINK1 KO neuronal cultures led to only 23.8±3.3%
(Fig. 4) cell death. In myocytes, ischaemia treatment also had a
greater effect on WT compared with PINK1 KO cells (3.1±0.5%
vs 5.1±0.8%) (Fig. 4), although this difference is not statistically
significant.
It is well established that neurons are dependent on oxidative
phosphorylation, and therefore, more susceptible to ischaemic
injury. Here we demonstrate that the increase in glycolysis
triggered by the PINK1 deficient state results in protection from
hypoxic-ischaemic injury. Myocytes are less susceptible to such
injury owing to their high glycolytic capacity.
The basal increase in Dym protects PINK1 KO myocytes
from Ca2+ stress
We investigated the effect of PINK1 deficiency on Ca2+
homeostasis in myocytes. We used Fura-2 AM (hereafter
referred to as Fura-2) as an indicator of the concentration of
cellular free Ca2+ ([Ca2+]c), and applied caffeine to initiate the
ryanodine-receptor-operated Ca2+ signal (as a physiological
calcium stimulus). Application of 10 mM caffeine induced a
transient increase in Ca2+ in both WT and PINK1 KO myocytes
(Fig. 5A,B). The Ca2+ signal in response to caffeine was in fact
lower in the PINK1 KO myocytes compared with WT
(75.7±6.1%, Fig. 5C). As Ca2+ uptake into mitochondria is
determined partly by the electrochemical gradient of Ca2+, we
hypothesise that the higher basal Dym in PINK1 KO myocytes
results in a higher mitochondrial buffering capacity for Ca2+
Fig. 3. ATP metabolism in PINK1 KO and WT
neurons and myocytes. (A) Measurements of
[Mg2+] indicate the rate of ATP depletion following
inhibition of glycolysis. Both WT and PINK1 KO
Mag-Fura loaded neurons were exposed to iodoacetic
acid (IAA), inducing a slow progressive increase in
[Mg2+] that culminated in cell lysis (abrupt increase
of signal owing to cell ATP collapse). (B) Time to
cell lysis and the rate of ATP depletion (measured by
[Mg2+]) in neurons and myocytes in response to the
inhibitor of glycolysis IAA. In PINK1 KO neurons
compared with WT, there was a significant increase
in ATP depletion rate and earlier cell lysis. There was
no difference in either measurement in PINK1 KO
and WT myocytes. (C) Time to cell lysis and ATP
depletion rate in response to NaN3 and oligomycin.
In PINK1 KO compared with WT, there was a
decrease in ATP depletion rate and prolongation of
the time to cell lysis. The effect was the same in both
neurons and myocytes. (D) Time to cell lysis and
ATP depletion rate in response to inhibition of ATP
synthesis (both glycolysis and oxidative
phosphorylation). In PINK1 KO neurons, there was
an increase in ATP depletion rate and a decrease in
time to cell lysis compared with that of the WT.
There was no significant difference between PINK1
KO and WT myocytes. Error bars represent mean ±
s.e.m; *P,0.05.
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compared with neurons. Of note, the high [Ca2+]c signal
induced by 10 mM caffeine did not lead to depolarization of the
mitochondria owing to the premature opening of the permeability
transition pore (PTP) (Fig. 5A,B). This is in marked contrast to
the effect of physiological Ca2+ stimuli in PINK1 KO neurons,
which induces mitochondrial Ca2+ overload, premature opening
of the PTP and profound mitochondrial depolarisation (Gandhi
et al., 2009).
These data strongly suggest that the metabolic environment
created by PINK1 deficiency in myocytes, that is, high levels of
glycolysis with increased ATP levels and higher basal Dy results
in a notable effect on the ability of muscle mitochondria to buffer
Ca2+ compared with that of neuronal mitochondria. This, in turn,
would be predicted to protect muscle cells from the Ca2+-induced
PTP opening that leads to neuronal cell death.
Discussion
We have previously demonstrated that PINK1 deficiency in
mouse and human neurons results in impaired Ca2+ efflux from
the mitochondria via the mitochondrial Na+/Ca2+ exchanger,
which causes Ca2+ accumulation inside the mitochondria (Gandhi
et al., 2009). Mitochondrial Ca2+ overload stimulates reactive
oxygen species (ROS) production, leading to inhibition of the
glucose transporter and subsequent reduction of substrate supply.
Reduction of substrate delivery results in decreased respiration
and decreased basal Dym, which can be restored by provision of
substrates of mitochondrial respiratory chain complexes I and II.
Both the decreased basal Dym and altered Ca2+ homeostasis
induced by PINK1 deficiency results in an increased vulnerability
Fig. 4. Cell death in response to ischaemic injury. PINK1 KO and WT
neuron and myocyte cultures were exposed to 50 minutes of ischaemia with a
normal concentration of glucose (10 mM) in the media. The percentage of cell
death is reduced in PINK1 KO cells. WT neurons, 40.3±3.0%; KO neurons,
23.8±3.3%; WT myocytes, 5.1±0.8%; KO myocytes, 3.3±0.5%, *P,0.05.
Error bars represent mean ± s.e.m.
Fig. 5. Skeletal muscle cell response to calcium
stimuli. (A,B) PINK1 KO and WT myocytes were
loaded with 5 mM Fura-2 and 500 nM TMRM. 10 mM
caffeine produced a rise in [Ca2+]c in both KO and WT
cells, and this rise in [Ca2+]c is associated with a slight
decrease in TMRM fluorescence, indicating
hyperpolarisation of the Dym. (C) The caffeine-
induced rise in [Ca2+]c signal was reduced in PINK1
KO myocytes compared with the WT, suggesting
higher mitochondrial Ca2+ uptake. Summary of mean
values normalised to WT are shown. KO, 75.6±6.1%,
*P,0.05. Error bars represent mean ± s.e.m.
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of neurons to open the permeability transition pore, followed by
cell death in response to physiological Ca2+ signals.
PINK1 is present in many brain regions. Furthermore, PINK1
mRNA is expressed in all adult (human) tissues, with the most
abundant levels of expression observed in the heart, skeletal
muscle and testis, and intermediate expression observed in the
liver, kidney, pancreas and brain (Unoki and Nakamura, 2001;
Gandhi et al., 2006; Taymans et al., 2006). Thus, PINK1
deficiency can occur in all human tissues, but only neurons are
dysfunctional, and only selective subgroups of neurons die in
PINK1-associated PD. The reason for this selectivity of cell type
is unclear, as the genetic and molecular defect occurs in all cells
expressing PINK1. Interestingly, other cells that are rich in
mitochondria, such as myocytes, do not undergo cell death in
mammalian models (e.g. human disease and transgenic mice).
We note that the PINK1-deficient Drosophila models do exhibit
significant muscle mitochondrial pathology, with much-less-
dramatic neuronal loss (Yang et al., 2006). This can be attributed
to differences in the rate of energetic metabolism in Drosophila
cells compared with mammalian cells (Noma, 2005).
It is well established that PINK1 deficiency leads to decreased
Dym in mammalian neurons as well as some non-neuronal cells,
suggesting a possible widespread mitochondrial phenotype
induced by PINK1 deficiency. For example, PINK1 deficiency
resulted in an ,16% decrease of Dym in human neurons and a
.40% decrease of Dym in human neuroblastoma cell lines
(Gandhi et al., 2006; Sandebring et al., 2009). In fibroblasts taken
from PD patients harbouring the V170G mutation, the Dym is
also,20% lower compared with that of control cells (Grunewald
et al., 2009). In this study, we have demonstrated a cell-specific
effect of PINK1 deficiency on the basal Dym. PINK1 deficiency
led to a decreased Dym in neurons and fibroblasts, which is
consistent with previous reports. In skeletal myocytes, however,
the basal Dym is substantially higher when PINK1 is absent. An
increased basal Dym has not been demonstrated previously in
PINK1 loss of function, and also not in any PD models, and has
major implications on the function of mitochondria in muscle
cells compared with neurons.
When cellular respiration is compromised and is insufficient
to maintain the Dym, the F1Fo-ATP synthase can switch from
producing ATP to consuming ATP to maintain the Dym
(Campanella et al., 2008). This reverse action of F1Fo-ATP
synthase as an ATPase has been observed previously in models of
cellular stress, such as ischaemia. In our previous study we
showed that, in PINK1 KO neurons, the Dym is partially
maintained by the F1Fo-ATP synthase working in reverse as a
proton-motive ATPase. The decrease in basal Dym in PINK1 KO
neurons is due to reduced substrate supply, and can be restored by
the provision of mitochondrial complex I and II substrates
(Gandhi et al., 2009). In this study, we found that PINK1 KO
skeletal myocytes utilise the same mechanism for maintaining
their mitochondrial membrane potential as PINK1 KO neurons –
that is, the Dym is partially maintained by hydrolysis of ATP in
the F1Fo-ATPase, rather than only by respiration. Furthermore,
this mechanism can be reversed by the provision of complex I
substrates. As the mechanism of maintaining the Dym is the
same in both neurons and myocytes, this raises the question of
why PINK1 deficiency leads to such a different outcome in the
basal mitochondrial potential of these cell types.
We propose that the difference in the Dym is due to the
difference in ATP levels in these different cell types, and we have
confirmed here that the ATP level is substantially higher in
skeletal muscle compared with brain. We have also confirmed
that the source of ATP production arises from increased
glycolysis in myocytes compared with neurons. We have
shown that PINK1 deficiency in neurons and myocytes
promotes an increase in glycolysis, presumably in order to
compensate for the impairment in mitochondrial respiration. In
fact, this increase in glycolytic activity in neurons is sufficient to
protect neurons from ischaemia-induced cell death. However,
there is an inherent difference in the glycolytic capacity between
neurons and myocytes, and it is well established that the skeletal
myocytes have a much higher glycolytic capacity compared with
that of neurons (Bolanos et al., 2010). Thus, their compensatory
mechanism for the impairment in respiration induced by PINK1
deficiency is highly effective, resulting in higher levels of ATP.
This leads to increased activity of the ATPase in order to
maintain a higher basal Dym than that of neurons.
It has been suggested in the literature that, under stress
conditions, in which oxidative phosphorylation is impaired,
neurons are unable to invoke glycolysis to maintain ATP
production (Almeida et al., 2001; Herrero-Mendez et al., 2009),
which is why they are more sensitive to stress. However, those
experiments inhibited oxidative phosphorylation by the
application of inhibitors. This acute treatment might not allow
the neurons enough time to compensate for impaired respiration
through increased glycolysis. In the case of PINK1 KO,
neurons are exposed to prolonged impairment of oxidative
phosphorylation and therefore, have sufficient time to increase
their glycolytic activity. Of note, however, although the elevated
glycolysis might provide more energy to the neurons, it might
also lead to increased oxidative stress. A recent study has shown
that the activation of glycolysis in neurons by overexpression of
Pfkfb3 (a key regulator of glyolysis) is accompanied by increased
oxidative stress and apoptosis. This was because of a marked
decrease in the oxidation of glucose through the pentose
phosphate pathway – a metabolic route involved in the
regeneration of reduced glutathione (Herrero-Mendez et al.,
2009). Therefore, the PINK1 KO-induced increase in glycolysis
might also contribute to the increased oxidative stress observed in
neuronal models.
Aside from generating energy through ATP production,
one of the main functions of mitochondria is maintaining
Ca2+ homeostasis. Dysfunction of Ca2+ homeostasis has
been implicated in a number of neurodegenerative diseases,
including Alzheimer’s disease, Huntington’s disease,
amyotrophic lateral sclerosis and PD (Abramov et al., 2004;
Mattson, 2007). Rapid uptake of cytosolic Ca2+ by mitochondria
is crucial for the survival of neurons and muscle cells, as both of
them are exposed to frequent and large influxes of cytosolic Ca2+,
which must be buffered by the mitochondria (Chan et al., 2007).
Recent studies have shown that neurons lacking PINK1 have a
reduced mitochondrial Ca2+ buffering capacity, owing to
increased basal mitochondrial free Ca2+ concentration ([Ca2+]m)
and decreased Dym (Gandhi et al., 2009). Here we demonstrated
that, in contrast to neurons, the absence of PINK1 in skeletal
myocytes in fact resulted in an increased mitochondrial Ca2+
buffering capacity. This can, in part, be explained by the high
Dym in PINK1 KO myocytes, enabling Ca2+ to be taken up into
the mitochondria. Furthermore, in PINK1 KO neurons, stimuli
that induce a [Ca2+]c signal can lead to extensive mitochondrial
depolarization and ultimately, cell death (Gandhi et al., 2009).
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This is particularly problematic in dopaminergic neurons, which
utilise a Ca2+ pacing mechanism and are, therefore, exposed to
high cytosolic Ca2+ fluxes. However, in skeletal myocytes, we
have shown that stimulation of a physiological [Ca2+]c signal did
not result in any mitochondrial depolarization. These results
indicate that myocytes are able to overcome the Ca2+
deregulation induced by PINK1 deficiency. We propose that
this is because myocytes are able to increase their glycolytic
activity in order to generate ATP, thereby maintaining a higher
basal Dym. Thus, in the face of PINK1 deficiency, myocytes
generate a metabolic environment that does not sensitise them to
the effects of Ca2+ toxicity or stress.
In summary, we have demonstrated that PINK1 KO leads to
impaired mitochondrial respiration, not only in neurons, but also
in other cells, such as skeletal myocytes. However, the response
to mitochondrial impairment varies in different cell types, which
might be because of a difference in metabolic capacity in the
different cell types. Our data demonstrated that skeletal myocytes
were able to maintain mitochondrial health, even when
their oxidative phosphorylation was impaired owing to PINK1
deficiency, which could be a result of their capacity to generate
more ATP through glycolysis. In the case of neurons, which
have a relatively low glycolytic capacity compared with that
of myocytes, the cell and mitochondrial function are heavily
impaired, although glycolysis is upregulated in response to
PINK1 KO (for a summary, see Fig. 6). These inherent
differences between neurons and myocytes might help
to explain the selective vulnerability of neurons in
neurodegenerative disease, such as PINK1-induced PD. Further
work in this area could help to explain why other mitochondria-
rich cells, such as myocytes, are not affected by the genetic
defect.
Materials and Methods
Animals
PINK1 KO mice were generated by Lexicon Genetics (The Woodlands, TX), and
their details have been published elsewhere (Wood-Kaczmar et al., 2008). Animal
husbandry and experimental procedures were performed in full compliance with
the UK Animal (Scientific Procedures) Act of 1986.
Cell culture
Mixed cultures of midbrain neurons and glial cells were prepared as described
previously (Vaarmann et al., 2010). Mice pups were obtained by crossing two
heterozygote animals and comparing homozygote KO or WT animals within a
litter. Cells at days 10–20 in vitro were used.
To prepare mixed cultures of skeletal myocytes and fibroblast cells, hind legs of
postnatal day 2–5 pups were taken – skins and fat tissues were carefully removed.
The tissues were then digested in 0.2% collagenase solution at 37 C˚ for 30–
40 minutes. The reaction was stopped by adding 2–3 ml fetal bovine serum (FBS),
and the tissue suspension was centrifuged at 2010 rpm (700 g) for 10 minutes. The
cell pellet was resuspended in pre-warmed growth medium [Dulbecco’s modified
Eagle’s medium (DMEM), containing 20% FBS, 100 i.u./ml penicillin and 200
i.u./ml streptomycin], and plated on 22 mm coverslips that were pre-coated with
0.2% gelatin for 1 hour at 37 C˚. Cells were then cultured in a humidified CO2
incubator (5% CO2 in air) at 37 C˚. After 2 or 3 days, the medium was changed to a
low-serum medium (DMEM containing 10% FBS without antibiotics), and was
subsequently changed every 3 or 4 days. All experiments were performed in vitro
between days 5 and 11 in culture.
Imaging mitochondrial membrane potential
For measurements of Dym, we used tetramethyl rhodamine methyl ester (TMRM),
[Invitrogen]. A reduction in TMRM fluorescence represents Dym depolarisation.
Neuronal cultures or myocyte cultures were loaded with 40 nM TMRM in a
HEPES-buffered salt solution (HBSS) [composed of (mM): 156 NaCl, 3 KCl, 2
MgSO4, 1.25 KH2PO4, 2 CaCl2, 10 glucose and 10 HEPES; pH adjusted to 7.35
with NaOH] for 40 minutes at room temperature – the dye was present during the
experiment. Z-stack confocal images were obtained using a Zeiss LSM 510
confocal microscope and a 406 oil-immersion objective. TMRM was excited
using the 543 nm laser line and fluorescence measured using a 560 nm long-pass
filter. TMRM fluorescence intensity was quantified by removing all background
signals and measuring the mean TMRM fluorescence intensity in the pixels
containing mitochondria – therefore, the signal is independent of mitochondrial
mass.
For measurements of Ca2+-induced mitochondrial depolarisation, TMRM was
again used in ‘redistribution mode’. In these experiments, the TMRM dye was
present continuously at 500 nM and allowed to equilibrate. Mitochondrial
depolarisation was then measured by the movement of dye from mitochondria into
the cytosol – that is, by observing the increase of TMRM signal in the cytosol.
ATP concentration measurements
PINK1 KO mice and WT littermates were culled by cervical dislocation. Midbrain,
cortex and skeletal muscle from the hind legs were dissected out and kept on ice.
The tissues were homogenised in 0.1 M Tris-acetate buffer containing 2 mM
EDTA (pH 7.75), and heated to 100 C˚ for 90 seconds. ATP levels in the midbrain,
cortex and skeletal muscle of the PINK1 KO mice and WT littermates were
measured using the ATP Biolumiescent Assay Kit (Sigma). Standard curves were
generated, and the amount of ATP in the samples was calculated according to the
standard curve.
SDS-PAGE and immunoblot analysis
Brain and skeletal muscle tissues were obtained from PINK1 KO and WT
littermates aged between 3 and 6 months. Tissues were lysed in 26 Laemmli
buffer. SDS-PAGE and immunoblotting were performed as described previously
(Wood-Kaczmar et al., 2008). Band densitometry was performed using Quantity
One software (BioRad).
Measurements of [Ca2+]c
All fluorescent dyes were obtained from Invitrogen. Mag-Fura AM or Fura-2 AM
(referred to as Mag-Fura and Fura-2, respectively) were used at 5 mM and loaded
with 0.005% Pluronic P-123 for 30 minutes at room temperature followed by two
washes with HBSS. Fluorescence measurements were obtained using an Olympus
microscope with a CCD camera. Both Mag-Fura and Fura-2 were excited
alternately at 340 nm and 380 nm. Emitted fluorescence was reflected through a
515 nm long-pass filter to a CCD camera. Images were analysed using Lucida
software.
Indirect measurements of cellular ATP by MagFura-2
As both primary neuronal and myocyte cultures contain a mixture of cell types,
including astrocytes and fibroblasts, kinetic measurements of ATP using
luminescence of luciferin–luciferase from whole cultures are unable to provide
Fig. 6. Scheme summarising differential effects of PINK1 deficiency in
neurons and myocytes. See text for further details.
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information about ATP in specific cell types. Mg2+ is released from MgATP upon
the hydrolysis of ATP (Leyssens et al., 1996), and therefore measurement of
cellular free magnesium ([Mg2+]c) using the Mg
2+-sensitive fluorescent probe
Mag-Fura can be used as an indication of ATP consumption. Application of
inhibitors of glycolysis and/or oxidative phosphorylation blocks ATP production in
cells, which eventually leads to ATP depletion and subsequent Mg2+ release. This
results in an increase in the Mag-Fura fluorescence. In addition to binding Mg2+,
Mag-Fura dye is also used as a low-affinity Ca2+ indicator, enabling the energy
capacity of the cell to be estimated. The energy capacity of the cell is defined as
the time between application of inhibitors of glycolysis/ATP-synthase (i.e.
cessation of ATP production) and the time of cell lysis (i.e. energetic collapse
due to total ATP depletion and inability to maintain Ca2+ homeostasis) (Abramov
et al., 2007).
Cell death analysis
Cells were incubated with 10 mM propidium iodide (PI) and 1 mg/ml Hoechst
33258 for 15 minutes and analysed using an Olympus microscope. Hoechst 33258
stains all nuclei, while PI stains only cells with a disrupted plasma membrane.
Dead cells (PI positive) were counted and expressed as a percentage of total nuclei.
Statistical analysis
All data were obtained from at least three independent experiments. All statistical
analyses were performed using a t-test. In all cases where WT cells were set at
100% (i.e. the mitochondrial membrane potential, GAPDH: ATPbeta ratio, and
basal Ca2+ level), a one-sample t-test was performed.
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